Trials / Recruiting
RecruitingNCT06835816
Amino Acid Supplementation in Continuous Renal Replacement Therapy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ICU patients treated with continuous renal replacement therapy is recruited prior to start of treatment. Blood samples are drawn and then dialysis start without amino acid supplementation. After a few hours samples are drawn from blood and dialysate. Then patients are given amino acid supplementation (33.5g/24hrs) for 20-24 hours. New samples are drawn and amino acid supplementation is increased to 67g/24hrs and new samples are drawn after additional 24 hours. Then CRRT will continue with the full amino acid supplementation (standars of care).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Amino acid supplementation (Glavamin, Fresenius Kabi) | Mixture of amino acids (67 g / 500 ml) given intravenously |
Timeline
- Start date
- 2025-02-03
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2025-02-19
- Last updated
- 2025-02-19
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT06835816. Inclusion in this directory is not an endorsement.